Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Sarcoma 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Leukemia, Myeloid, Acute 5Osteosarcoma 4Melanoma 4Lymphoma 4Leukemia 4Wilms Tumor 3Neuroblastoma 3Hematologic Neoplasms 3Rhabdoid Tumor 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neoplasms 2Myelodysplastic Syndromes 2Kidney Neoplasms 2Hepatoblastoma 2Graft vs Host Disease 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Burkitt Lymphoma 2Stomach Neoplasms 1Sarcoma, Ewing 1Sarcoma, Clear Cell 1Rhabdomyosarcoma 1Retinoblastoma 1Recurrence 1Rectal Neoplasms 1Primary Myelofibrosis 1Pancreatic Neoplasms 1

Interventions

Cyclophosphamide 5fludarabine 4thymoglobulin 1Pyridostigmine Bromide 1Oxaloacetic Acid 1Methylprednisolone 1Mesna 1Hizentra 1Hematopoietic Stem Cell Transplantation 1Granulocyte Colony-Stimulating Factor 1Exercise 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Myasthenia Gravis × Mesna × Clear all
NCT00424489 2018-08-31

Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis

Northwestern University

Phase 1 Terminated
9 enrolled 8 charts

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡